Press Release

Research News Community Spotlight Press Release Research Spotlight

RAND report shows benefit of investment in future health outcomes for adults with Down syndrome

10/1/2024 | For immediate release | Contact: Kate O'Neill (koneill@lumindidsc.org) Investment in Alzheimer’s Research Today…

Kate O’NeillSeptember 18, 2024

Community Spotlight Press Release Research Spotlight

Pathways to Parity Program Approved for $250K PCORI Engagement Award

Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who…

Shannon BergstresserAugust 13, 2024

Community Spotlight Press Release Research News

FDA issues approval for new Alzheimer’s drug Kisunla; Down syndrome community is optimistic

FDA issues approval for Kisunla, new Alzheimer's drug; Down syndrome community optimistic On Tuesday, July…

Kate O’NeillJuly 3, 2024

Alzheimer's disease in people with Down syndrome

Community Spotlight Press Release Research News Research Spotlight

Down syndrome population will see a clinical trial of new Alzheimer’s drug

Major pharmaceutical company announces Down syndrome population will see a clinical trial of new Alzheimer’s…

Kate O’NeillJune 11, 2024

Press Release Research News

MapHabit Study: Assistive Technology Has Positive Outcomes for Children with Down Syndrome

Study Finds Assistive Technology Has Positive Outcomes for Children with Down Syndrome and Their Caregivers …

Kate O’NeillJune 2, 2023

Research News Press Release Research Spotlight

Expert panel addresses inequitable access to Alzheimer’s drugs for adults with Down syndrome

Seeking to rectify existing federal and state policies which prevent people with intellectual disabilities from…

Kate O’NeillJune 1, 2023

Tau Tangles in Down syndrome related Alzheimer's disease

Research Spotlight Press Release Research News

With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research

2/22/2023 (Burlington, MA) – Today the LuMind IDSC Foundation, a leading national Down syndrome research…

Kate O’NeillFebruary 23, 2023

Press Release Research Spotlight

DS-CTN Data and Safety Monitoring Board (DSMB)

LuMind IDSC and the Down Syndrome Clinical Trials Network are pleased to announce the launch…

Kate O’NeillNovember 16, 2022

Press Release

ANNOUNCEMENT: Richard Fisher Named as Chief Scientific Officer

Date: 7/28/2022 Last week, Richard A. Fisher, Ph.D. joined LuMind IDSC as Chief Scientific Officer.…

CapetivateJuly 28, 2022

Press Release

Down Syndrome Community Responds to CMS Decision

Date: 4/8/2022 Your advocacy is making a difference! The Down Syndrome Coalition, along with our…

CapetivateApril 8, 2022

RAND report shows benefit of investment in future health outcomes for adults with Down syndrome

Pathways to Parity Program Approved for $250K PCORI Engagement Award

FDA issues approval for new Alzheimer’s drug Kisunla; Down syndrome community is optimistic

Down syndrome population will see a clinical trial of new Alzheimer’s drug

MapHabit Study: Assistive Technology Has Positive Outcomes for Children with Down Syndrome

Expert panel addresses inequitable access to Alzheimer’s drugs for adults with Down syndrome

With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research

DS-CTN Data and Safety Monitoring Board (DSMB)

ANNOUNCEMENT: Richard Fisher Named as Chief Scientific Officer

Down Syndrome Community Responds to CMS Decision

Recent Posts

CONTACT LUMIND IDSC

QUICK LINKS

NEED MORE INFORMATION?